GlassScriptPhysician profile
David S Balle
NPI 1356334841
$81,152.12
in general payments reported to CMS, 2019-2025
12 companies · $5,285 in 2025
The $5,285 reported for 2025 was more than what 90% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $7,157 · 2021: $7,682 · 2022: $24K · 2023: $11K · 2024: $5,008 · 2025: $5,285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $1,404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,500.00 |
| Food and Beverage | $1,403.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $66,299.73 | 2019-2025 | Dysport, Nemluvio |
| Allergan, INC. | $13,303.98 | 2019-2022 | |
| Abbvie INC. | $653.17 | 2019-2025 | Botox |
| Revance Therapeutics, INC. | $345.48 | 2024-2025 | Daxxify |
| Genzyme Corporation | $267.96 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $96.52 | 2019-2025 | Winlevi |
| Janssen Biotech, INC. | $89.00 | 2021 | |
| Leo Pharma INC. | $23.79 | 2022 | |
| Lilly USA, LLC | $21.31 | 2023 | Taltz, Olumiant |
| Epi Health, LLC | $17.53 | 2019 | |
| Arcutis Biotherapeutics, INC. | $17.08 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $16.57 | 2025 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Balle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.